
    
      This is a Phase I, Single Center, Randomized, Double-blind, Placebo-controlled Study to
      Evaluate the Tolerability and Pharmacokinetics of HEC53856 capsule in Healthy Adult Subjects.
      The study consists of three parts, single dose ascending, multiple dose ascending and food
      effect testing. Within each part participants will be randomized to either drug or placebo.
    
  